Jeanne Regnante is Senior Vice President of Community Education for Sustainable Healthy Communities, LLC, a wholly-owned subsidiary of the National Minority Quality Forum based in Washington, DC. In her role she launched and is chair of the Diverse Cancer Communities Working Group, a unique 25-member organization focused on optimizing access to care, treatment, and inclusion of clinical trials for racial and ethnic minorities and underserved populations in the US. Recently, Jeanne was the lead author of a publication in the Journal of Oncology Practice, which exposed the best practices of eight US cancer centers who can accrue diverse populations with sustained success.
In 2018, Jeanne was recognized for launching the Cancer Index, a public commitment to the Biden Cancer Initiative, which enables anyone to map cancer patient prevalence and demographics to a zip code level to better target education, advocacy and research in the US. Jeanne’s experience includes Founder of Patient-Focused Medicines Development (PFMD) based in Brussels, and a member of several public-private projects and author of publications focused on optimizing patient insights in research and health equities. She has 30+ years of work experience at Merck & Co., which includes Head of Global Patient Engagement and Chief of Staff to Merck’s Chief Medical Officer and head of an industry leading Global Investigator Studies Program. Jeanne received her BS degree in Pre-Medical Sciences from Villanova University and is a Six Sigma Executive Belt. She loves anywhere in Europe, biking, museums, arranging flower boxes, and believes that networking is a superpower of leaders.